Standard clinical trials used to test new medicines are slow and cumbersome. The pandemic has shown that a new kind of trial is far quicker, but is it reliable enough?
Standard clinical trials used to test new medicines are slow and cumbersome. The pandemic has shown that a new kind of trial is far quicker, but is it reliable enough?
Share this Article
Recommended